Atrial Fibrillation
Conditions
Brief summary
This is a prospective, non-randomized study to refine the Study Watch's algorithm for AF detection within both persistent and paroxysmal AF subjects. The study will also collect data from an FDA-cleared wearable ECG sensor.
Interventions
Study Watch is a miniaturized physiological data monitoring and data collection device for continuous recording of physiological and environmental data
Sponsors
Study design
Eligibility
Inclusion criteria
* At least 18 years old * Able to read and speak English * Able and willing to sign written Informed Consent * Interest in participating in the study * Subjects with a known history of AF (including persistent or paroxysmal AF) * Without significant limitation in ability to participate in the study, in the opinion of the investigator.
Exclusion criteria
* Currently in a paced rhythm * Known severe allergy to nickel or metal jewelry * Known allergic reaction to adhesives or hydrogels or with family history of adhesive skin allergies
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Estimate of the accuracy of algorithm based PPG irregular rhythm detection in a study population with a history of paroxysmal or persistent atrial fibrillation (AF) | At least 60 minutes | Sensitivity estimate for PPG irregular rhythm detection vs. a multi-lead Holter ECG rhythm |
| PPG- and ECG-based continuous AF-detection algorithms on Study Watch in a free-living (home) setting by comparing the Study Watch data with an FDA-cleared wearable ECG sensor data. | 14 days | Number of AF events identified from FDA-cleared ECG Device |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Estimate of the accuracy of algorithm based PPG irregular rhythm detection in a study population with a history of paroxysmal or persistent atrial fibrillation (AF) | At least 60 minutes | Predictive value estimate for PPG irregular rhythm detection vs. a multi-lead Holter ECG rhythm |
| Spontaneously-reported participant usability feedback for Study Watch and its ECG feature in a free-living (home) setting with the target AF population. | 14 days | Qualitative listing of participant-reported feedback |
Countries
United States